Stéphane Supplisson

Stéphane Supplisson

Auto-generated profile, based on publicly available information

Stéphane Supplisson

Department of Physiology, University of California, School of Medicine, Los Angeles 90024-1751

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2000 in Neuron
Verified
Journal Article
Closed access
MRMichel J Roux
Michel J Roux
SSStéphane Supplisson
Stéphane Supplisson

4 June 2006 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MRMark I Rees
Mark I Rees
KHKirsten Harvey
Kirsten Harvey
BPBrian R Pearce
Brian R Pearce
SCSeo-Kyung Chung
Seo-Kyung Chung
IDIan C Duguid
Ian C Duguid
Robert HarveyRobert Harvey
Robert Harvey

15 June 1993 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
DLD D Loo
D D Loo
AHA Hazama
A Hazama
SSS Supplisson
S Supplisson
ETE Turk
E Turk
EWE M Wright
E M Wright
An important class of integral membrane proteins, cotransporters, couple solute transport to electrochemical potential gradients; e.g., the Na+/glucose cotransporter uses the Na+ electrochemical potential gradient to accumulate sugar in cells. So far, kinetic analysis of cotransporters has mostly been limited to steady-state parameters. In this study, we have examined pre-steady-state kinetics of Na+/glucose cotransport. The cloned human transporter (hSGLT1) was expressed in Xenopus oocytes, and voltage-clamp techniques were used to monitor current transients after step changes in membrane potential. Transients exhibited a voltage-dependent time constant (tau) ranging between 2 and 10 ms. The charge movement Q was fitted to a Boltzmann relation with maximal charge Qmax of approximately 20 nC, apparent valence z of 1, and potential V0.5 of -39 mV for 50% Qmax. Lowering external Na+ from 100 to 10 mM reduced Qmax 40%, shifted V0.5 from -39 to -70 mV, had no effect on z, and reduced the voltage dependence of tau. Qmax was independent of, but tau was dependent on, temperature (a 10 degrees C increase increased tau by a factor of approximately 2.5 at -50 mV). Addition of sugar or phlorizin reduced Qmax. Analyses of hSGLT1 pre-steady-state kinetics indicate that transfer upon a step of membrane potential in the absence of sugar is due to two steps in the reaction cycle: Na+ binding/dissociation (30%) and reorientation of the protein in the membrane field (70%). The rate-limiting step appears to be Na+ binding/dissociation. Qmax provides a measure of transporter density (approximately 10(4)/microns 2). Charge transfer measurements give insight into the partial reactions of the Na+/glucose cotransporter, and, combined with genetic engineering of the protein, provide a powerful tool for studying transport mechanisms.

15 June 1997 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
SSStéphane Supplisson
Stéphane Supplisson
CBClaude Bergman
Claude Bergman
We present evidence that membrane transporters can control the membrane receptor’s agonist concentration in restricted extracellular spaces of a biological model. The model is constructed by co-expressing glycine/Na/Cl cotransporters (GLYT1b) and NMDA receptors (NMDARs) (composed of the subunits NR1 and NR2A or NR2B) inXenopusoocytes. We use the high-affinity glycine site of the NMDARs as a sensor of the actual juxtamembrane glycine concentration. We show that glycine uptake by GLYT1b dramatically reduces NMDAR currents by reducing the glycine concentration in extracellular spaces in which diffusion is restricted. This effect appears only in oocytes in which GLYT1b and NMDAR are co-expressed. It is Na+- and voltage-dependent, and is abolished when Na+is replaced by Li+and when glycine is replaced byd-serine (a coagonist of the NMDAR that is not transported by GLYT1b). These results demonstrate the ability of the GLYT transporter to reduce glycine concentration at the level of NMDARs in restricted diffusion spaces. This observation could account for a prevalent role of membrane transporters in the modulation of synapse transmission in the CNS. From a more general point of view, our results draw attention to possible significant discrepancies between local concentrations at the level of substrate targets in biological membranes and their concentration in the bulk solution when membrane transporters are present.

1 January 1992 in The Journal of Membrane Biology
Verified
Journal Article
Closed access
PDF file
LPLucie Parent
Lucie Parent
SSStéphane Supplisson
Stéphane Supplisson
DLDonald D. F. Loo
Donald D. F. Loo
EWErnest M. Wright
Ernest M. Wright

24 September 2008 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
FRFrance Rousseau
France Rousseau
KAKarin Renee Aubrey
Karin Renee Aubrey
SSStéphane Supplisson
Stéphane Supplisson
At inhibitory synapses, glycine and GABA are accumulated into synaptic vesicles by the same vesicular transporter VGAT/VIAAT (vesicular GABA transporter/vesicular inhibitory amino acid transporter), enabling a continuum of glycine, GABA, and mixed phenotypes. Many fundamental aspects of the presynaptic contribution to the inhibitory phenotypes remain unclear. The neuronal transporter GlyT2 is one of the critical presynaptic factors, because glycinergic transmission is impaired in knock-outGlyT2−/−mice and mutations in the human GlyT2 gene slc6a5 are sufficient to cause hyperekplexia. Here, we establish that GlyT2-mediated uptake is directly coupled to the accumulation of glycine into recycling synaptic vesicles using cultured spinal cord neurons derived from GlyT2–enhanced green fluorescent protein transgenic mice. Membrane expression of GlyT2 was confirmed by recording glycine-evoked transporter current. We show that GlyT2 inhibition induces a switch from a predominantly glycine to a predominantly GABA phenotype. This effect was mediated by a reduction of glycinergic quantal size after cytosolic depletion of glycine and was entirely reversed by glycine resupply, illustrating that the filling of empty synaptic vesicles is tightly coupled to GlyT2-mediated uptake. Interestingly, high-frequency trains of stimuli elicit two phases of vesicle release with distinct kinetic requirements for glycine refilling. Thus, our results demonstrate the central role played by GlyT2 in determining inhibitory phenotype and therefore in the physiology and pathology of inhibitory circuits.